EN
Melanoma frightens people by its reputation more than by the course of the disease itself: everyone has heard that it is “the most dangerous”, and that obscures the main point — how manageable it is when dealt with in time and accurately. Usually a person arrives with a mole already removed and a report that sounds alarming but does not answer the question of what to do next. German oncology starts with exactly that question: not with emotions but with facts about the particular tumour.
How people usually arrive
Most often the mole or patch has already been removed by the time they come, and they have the histology report in hand. It contains the things that matter in melanoma: how deep the tumour grew into the skin and whether it was ulcerated. It is on that, not on the size of the patch by eye, that everything that follows depends. The question people bring to Germany usually runs: is what has been done enough, and has anything important been missed?
How the diagnosis is confirmed in Germany
The first step is reviewing the slide. A German pathologist re-examines the tissue already taken: confirms that it really is melanoma and measures the depth of invasion and the other features on which the extent of treatment depends. That is not bureaucracy — whether anything beyond the operation already done is needed depends on that precision.
If the depth of the tumour gives reason to check whether cells have travelled further, a sentinel lymph node biopsy is done — the node to which lymph from the site of the tumour drains first. It is located and examined: a clear node is a weighty argument that the process is local. Ultrasound, CT or MRI is added as needed, and in advanced disease, positron emission tomography (PET), which shows tissue activity throughout the body.
A distinct and important part is molecular analysis of the tumour. Some melanomas carry particular changes in their genes (the best known being in the BRAF gene), and that is not an abstract detail: which modern drugs will suit this particular case depends directly on the result. So diagnosing melanoma today answers not only “what is this” but “what should this be treated with in your case”.
Which approaches are used
The basis of treatment for early melanoma is surgery. The tumour is excised with a margin of healthy tissue around it so that no cells are left at the edge. In many cases, where the melanoma is thin and has not gone beyond the skin, that is where treatment ends — monitoring follows. This is exactly the case where “little intervention” means “enough”, not “undertreated”.
If the tumour is deeper or the lymph nodes are involved, drug therapy is added to the operation. The main shift of recent years has happened here: two more targeted approaches have largely replaced the old chemotherapy. Targeted drugs act on a specific fault in the tumour cells — and are chosen by the molecular analysis. Immunotherapy works differently: it helps the body’s own immune system to recognise and hold back the tumour. Radiotherapy is used in melanoma more rarely and selectively — to treat a single deposit, for instance.
Which of these routes to take is decided not by one doctor but by a tumour board — oncologist, surgeon, dermato-oncologist, radiation oncologist and pathologist look at the case together and agree a common approach. That format reduces the risk of something being prescribed out of habit or missed.
When a second opinion makes sense
Melanoma is a situation where a second opinion is particularly apt. If the diagnosis has been made at home but doubts about the approach remain, a German specialist reviews the slides and the images and says plainly whether they confirm the diagnosis, whether what has been done is enough and what should be added. Sometimes that spares an unnecessary intervention; sometimes it opens a treatment option that was never mentioned at home.
This material is for information only and does not replace a consultation with a doctor. Whether treatment is possible, what it will involve and what it will achieve can be determined only after an examination at the clinic in person.